Cargando…

Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme

BACKGROUND: Pulmonary arterial hypertension (PAH) is the leading cause of death in systemic sclerosis (SSc). Annual screening with echocardiogram (ECHO) is recommended. We present the methodological aspects of a PAH screening programme in a large Australian SSc cohort, the epidemiology of SSc-PAH in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morrisroe, Kathleen, Stevens, Wendy, Sahhar, Joanne, Rabusa, Candice, Nikpour, Mandana, Proudman, Susanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341425/ https://www.ncbi.nlm.nih.gov/pubmed/28270192 http://dx.doi.org/10.1186/s13075-017-1250-z

Ejemplares similares

Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study
por: Morrisroe, Kathleen, et al.
Publicado: (2016)

Cost‐Effectiveness of Combination Therapy for Patients With Systemic Sclerosis–Related Pulmonary Arterial Hypertension
por: Tran‐Duy, An, et al.
Publicado: (2021)

Quantifying the direct public health care cost of systemic sclerosis: A comprehensive data linkage study
por: Morrisroe, Kathleen, et al.
Publicado: (2017)

A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis
por: Hao, Yanjie, et al.
Publicado: (2015)

Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension
por: Morrisroe, Kathleen, et al.
Publicado: (2017)

The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia
por: Morrisroe, Kathleen, et al.
Publicado: (2019)

Digital ulcers in systemic sclerosis: their epidemiology, clinical characteristics, and associated clinical and economic burden
por: Morrisroe, Kathleen, et al.
Publicado: (2019)

Gastric antral vascular ectasia in systemic sclerosis: a study of its epidemiology, disease characteristics and impact on survival
por: Morrisroe, Kathleen, et al.
Publicado: (2022)

The association of low complement with disease activity in systemic sclerosis: a prospective cohort study
por: Esposito, James, et al.
Publicado: (2016)

Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis
por: Fairley, Jessica L., et al.
Publicado: (2023)

Potential role of the lectin pathway of complement in the pathogenesis and disease manifestations of systemic sclerosis: a case-control and cohort study
por: Osthoff, Michael, et al.
Publicado: (2014)

Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study
por: Ngian, Gene-Siew, et al.
Publicado: (2012)

The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study
por: Thakkar, Vivek, et al.
Publicado: (2013)

N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study
por: Thakkar, Vivek, et al.
Publicado: (2012)

Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort
por: Nikpour, Mandana, et al.
Publicado: (2011)

Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosis
por: Moxey, Jayne, et al.
Publicado: (2019)

Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol
por: Calderone, Alicia, et al.
Publicado: (2016)

Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease Subtypes
por: Hanson, Aimee L., et al.
Publicado: (2022)

IFNL3 genotype is associated with pulmonary fibrosis in patients with systemic sclerosis
por: Metwally, Mayada, et al.
Publicado: (2019)

Myocardial fibrosis and arrhythmic burden in systemic sclerosis
por: Ross, Laura, et al.
Publicado: (2022)

An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3
por: Zochling, Jane, et al.
Publicado: (2014)

Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations
por: Hoa, S., et al.
Publicado: (2016)

Screening for pulmonary arterial hypertension in systemic sclerosis
por: Weatherald, Jason, et al.
Publicado: (2019)

Using magnetic resonance imaging to map the hidden burden of muscle involvement in systemic sclerosis
por: Ross, Laura, et al.
Publicado: (2022)

Cardiovascular disease in systemic sclerosis - an emerging association?
por: Ngian, Gene-Siew, et al.
Publicado: (2011)

Sudden Cardiac Death in Systemic Sclerosis: Diagnostics to Assess Risk and Inform Management
por: Ross, Laura, et al.
Publicado: (2021)

Improved Survival for Patients with Systemic Sclerosis–associated Pulmonary Arterial Hypertension: For Real?
por: Xanthouli, Panagiota
Publicado: (2022)

Determinants of left ventricular structure, filling and long axis function in systemic sclerosis
por: Peverill, Roger E., et al.
Publicado: (2021)

Epidemiology and Management of Chronic Thromboembolic Pulmonary Hypertension in Greece. Real-World Data from the Hellenic Pulmonary Hypertension Registry (HOPE)
por: Demerouti, Eftychia, et al.
Publicado: (2021)

The Effect of Body Fat Distribution on Systemic Sclerosis
por: Villanueva-Martin, Gonzalo, et al.
Publicado: (2022)

Right ventricular myocardial deoxygenation in patients with pulmonary artery hypertension
por: Sree Raman, Karthigesh, et al.
Publicado: (2021)

Epidemiology of pulmonary hypertension in the elderly
por: Örem, Cihan
Publicado: (2017)

Risk factors for the development of systemic sclerosis: a systematic review of the literature
por: Abbot, Samuel, et al.
Publicado: (2018)

Multifactorial Pulmonary Hypertension in Systemic Sclerosis
por: Hussain, Habiba, et al.
Publicado: (2020)

Epidemiology and initial management of pulmonary arterial hypertension: real-world data from the Hellenic pulmOnary hyPertension rEgistry (HOPE)
por: Arvanitaki, Alexandra, et al.
Publicado: (2019)

Pulmonary Arterial Hypertension In Systemic Sclerosis: Challenges In Diagnosis, Screening And Treatment
por: Saygin, Didem, et al.
Publicado: (2019)

Pulmonary hypertension in systemic sclerosis: different phenotypes
por: Launay, David, et al.
Publicado: (2017)

Pulmonary hypertension phenotypes in patients with systemic sclerosis
por: Haque, Ashraful, et al.
Publicado: (2021)

The Importance of Echocardiographic Screening for Pulmonary Arterial Hypertension in Korean Patients with Systemic Sclerosis
por: Kim, Hack-Lyoung
Publicado: (2016)

Screening for Pulmonary Hypertension in Systemic Sclerosis—A Primer for Cardio-Rheumatology Clinics
por: Giucă, Adrian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s39fkoft0s1ie5bajrk3sit5am